Shanghai Pharmaceuticals Holdings ADR (SHPMY) – cijena dionice i vijesti

Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia

Shanghai Pharmaceuticals Holdings ADR – informacije

Glavni izvršni direktor-

Zaposlenici48,6 tis.

Osnovano18. sij 1994.

Sjedište-

SektorHealth care provider

Web-lokacijasphchina.com

Sve vrijednosti su u valuti CNY	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	73,48 mlr.	68,51 mlr.	75,26 mlr.	72,21 mlr.
Trošak prodane robe	66,03 mlr.	60,55 mlr.	67,17 mlr.	64,09 mlr.
Trošak prihoda	66,03 mlr.	60,55 mlr.	67,17 mlr.	64,09 mlr.
Izdaci za istraživanje i razvoj	556,53 mil.	824,53 mil.	468,22 mil.	502,64 mil.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	4,70 mlr.	4,97 mlr.	4,59 mlr.	4,65 mlr.
Poslovni rashod	5,58 mlr.	5,91 mlr.	5,47 mlr.	5,55 mlr.
Ukupni poslovni rashodi	71,60 mlr.	66,47 mlr.	72,63 mlr.	69,64 mlr.
Poslovni prihod	1,88 mlr.	2,04 mlr.	2,63 mlr.	2,57 mlr.
Ostali neposlovni prihod	−84,84 mil.	−63,65 mil.	−47,88 mil.	−7,43 mil.
Zarada prije poreza uključujući neuobičajene stavke	1,48 mlr.	1,52 mlr.	2,42 mlr.	3,21 mlr.
Zarada prije poreza isključujući neuobičajene stavke	1,61 mlr.	1,44 mlr.	2,27 mlr.	3,03 mlr.
Izdaci za porez na dohodak	485,91 mil.	534,14 mil.	569,09 mil.	720,64 mil.
Efektivna porezna stopa	32,89 %	35,10 %	23,52 %	22,43 %
Ostali poslovni rashodi	129,62 mil.	271,29 mil.	132,16 mil.	186,62 mil.
Neto dohodak	688,20 mil.	577,49 mil.	1,42 mlr.	2,09 mlr.
Neto profitna marža	0,94 %	0,84 %	1,88 %	2,89 %
Zarada po dionici	-	-	-	-
Prihod od kamata i ulaganja	206,57 mil.	-	38,70 mil.	873,52 mil.
Izdaci za kamate	−393,02 mil.	−470,36 mil.	−347,64 mil.	−358,39 mil.
Neto izdaci za kamate	−186,45 mil.	−470,36 mil.	−308,94 mil.	515,13 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	2,26 mlr.	2,54 mlr.	3,12 mlr.	3,07 mlr.
Dobit ili gubitak od prodaje imovine	39,99 mil.	−157,15 mil.	-	−179,70 mil.

Pitajte bilo što